The Technical AnalystExchange: OTC Sector: Technology Industry: Solar
MabCure, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0000
America/New_York / 18 apr 2024 @ 12:20
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.515 mill |
| EPS: | -0.0100 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 32 182 mill |
| Avg Daily Volume: | 0.0000 mill |
| RATING 2024-01-30 |
|---|
| C |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/10 | 4/10 | 1/11 | 2/11 | 3/11 | 4/11 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 6.80 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -0.269 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0001 - 0.0001 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2011-05-19 | Berdugo Gad | Buy | 200 000 | Stock Option (Right to Buy) |
| 2011-09-24 | Berdugo Gad | Sell | 120 000 | Stock Option (Right to Buy) |
| 2008-07-07 | Katz Steven | Buy | 0 |
| INSIDER POWER |
|---|
| 0.00 |
| Last 2 transactions |
| Buy: 200 000 | Sell: 120 000 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0000 (0.00% ) |
| Volume | 0.0026 mill |
| Avg. Vol. | 0.0000 mill |
| % of Avg. Vol | 6 450.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MBCI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MBCI
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.